NFKB1 and Miyoshi myopathy: We found that the NF-κB pathway, an activated pathway contributing to the development and drug resistance of MM cells, was enriched in the KEGG annotation of down-regulated DEGs, suggesting that JA may have exerted its anti-MM effect by inhibiting the NF-κB pathway.